Literature DB >> 25790346

Cardiotoxicity related to long-term trastuzumab therapy in metastatic breast cancer: the potential role of treatment duration and cardiac risk factors.

Barbara Pistilli1, Andrea Marcellusi, Luciano Latini, Roberto Accardi, Benedetta Ferretti, Giovanni Benedetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25790346     DOI: 10.1111/tbj.12412

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  2 in total

Review 1.  Trastuzumab cardiotoxicity: from clinical trials to experimental studies.

Authors:  Balazs T Nemeth; Zoltan V Varga; Wen Jin Wu; Pal Pacher
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

2.  Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999-2018.

Authors:  Henry G Kaplan; Judith A Malmgren; Boya Guo; Mary K Atwood
Journal:  Breast Cancer Res Treat       Date:  2022-07-22       Impact factor: 4.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.